pharma
FDA greenlights first oral, daily, non-statin therapy for lowering LDL-Cholesterol
February 25, 2020Manufacturing and Production, Sales and Marketing Esperion, FDA, Nexletol, pharma
Esperion’s ATP Citrase Lyase (ACL) inhibitor Nexletol (bempedoic acid) has secured approval from the FDA, it has emerged. It is …
2020 Veeva Unified Clinical Operations Survey
February 24, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing pharma, survey, veeva
Every year, Veeva asks clinical professionals to take part in the Veeva Unified Clinical Operations Survey to help the industry …
FDA approves first adjuvanted quadrivalent flu vaccine in over-65s
February 24, 2020Sales and Marketing FDA, flu, influenza, pharma, seqirus
The FDA has just authorised its first adjuvanted quadrivalent influenza vaccine, it has been announced. Seqirus’ Fluad Quadrivalent (influenza vaccine, adjuvanted) …
Clover Biopharmaceuticals partners up with GSK to accelerate coronavirus vaccine development
February 24, 2020Sales and Marketing China, Clover Biopharmaceuticals, GSK, coronavirus, pharma
Chinese biotech firm Clover Biopharmaceuticals has joined the race to develop interventions against the ongoing coronavirus outbreak with the announcement …
Eli Lilly’s Trulicity approved in US to reduce cardiovascular events in type 2 diabetes patients
February 24, 2020Sales and Marketing Eli Lilly, Trulicity, cardiovascular disease, pharma
Eli Lilly’s Trulicity (duraglutide) has been awarded marketing authorisation from the FDA as a therapy to reduce major adverse cardiovascular …
Lundbeck’s Vyepti secures US approval for migraine prevention
February 24, 2020Sales and Marketing FDA, Lundbeck, Vyepti, migraine, pharma
Lundbeck’s Vyepti (eptinezumab-jjmr) has secured approval from the FDA, it has emerged, for the prevention of migraine in adult patients. …
FDA approval for Baudax Bio’s non-opioid painkiller Anjeso
February 24, 2020Sales and Marketing Anjeso, FDA, opioids, pharma
Baudax Bio has revealed the FDA approval of its non-opioid painkiller Anjeso (meloxicam injection) as a therapy for the management …
Merck KGaA to flog Allergopharma business to Dermapharm
February 21, 2020Medical Communications, Sales and Marketing Allergopharma, Dermapharm, Merck KGaA, pharma
German-based drugmaker Merck KGaA has confirmed its intention to divest its allergy business Allergopharma to Dermapharm, another German manufacturer of …
Teva’s Austedo fails in two paediatric Tourette’s syndrome trials
February 21, 2020Medical Communications, Research and Development Austedo, Teva, pharma, tourette's
Israeli firm Teva has shared disappointing results for its vesicular monoamine transporter 2 (VMAT2) Austedo (deutetrabenazine) after it failed to …
New Keytruda dosing schedule rejected in six cancers by the FDA
February 20, 2020Sales and Marketing Cancer, FDA, MSD, keytruda, pharma
MSD’s blockbuster immunotherapy Keytruda has been stopped in its tracks by the FDA after the US regulator rejected its application …
FDA approved over 1,000 generic drugs in 2019
February 20, 2020Research and Development, Sales and Marketing FDA, generic drugs, pharma
The FDA covered a lot of ground in 2019 when it came to generic drugs, awarding at least tentative approval …
Europe approves first treatment for transthyretin amyloidosis in cardiomyopathy patients: Pfizer’s Vyndaqel
February 19, 2020Research and Development, Sales and Marketing Europe, Pfizer, Vyndaqel, pharma, transthyretin amyloidosis
The European Commission (EC) has awarded marketing approval to Pfizer’s Vyndaqel (tafamidis), it has emerged, for the treatment of wild-type …
Opdivo + cabiralizumab combo falls flat in advanced pancreatic cancer
February 19, 2020Research and Development Bristol-Myers Squibb, Five Prime Therapeutics, Pancreatic cancer, cabiralizumab, opdivo, pharma
Five Prime Therapeutics and Bristol-Myers Squibb have confirmed that their randomised Phase 2 trial investigating the efficacy of the former’s …
Janssen shows off Phase 3b interim data for Stelara in Crohn’s disease
February 18, 2020Manufacturing and Production, Research and Development Crohn’s disease, Janssen, Stelara, crohn's disease, pharma
Janssen has revealed new interim Phase 3b data from a study investigating the efficacy of Stelara (ustekinumab) in the treatment …
Novartis’ Beovu approved in Europe after outclassing Eylea in wet age-related macular degeneration
February 18, 2020Manufacturing and Production, Sales and Marketing Beovu, Eylea, Novartis, Regeneron, macular degeneration, pharma
The European Commission (EC) has chosen to approve Novartis’ Beovu (brolucizumab) injection, it has emerged, as a treatment for wet …
Latest content
Five Facts about cardiovascular disease
